Article Text

PDF

Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review
  1. J Noble1,
  2. N Weizblit2,
  3. M O Baerlocher3,
  4. K T Eng1,4
  1. 1
    Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada
  2. 2
    Faculty of Medicine, University of Ottawa, Ottawa, Canada
  3. 3
    Department of Radiology and Diagnostic Medical Imaging, University of Toronto, Toronto, Canada
  4. 4
    Sunnybrook Health Sciences Centre, Toronto, Canada
  1. Dr J Noble, Toronto Western Hospital, 399 Bathurst St, Rm 7E-401, Toronto, ON, Canada, M5T 2S8; jason.noble{at}utoronto.ca

Abstract

Introduction: This review provides an updated analysis of the evidence supporting intra-arterial thrombolysis (IAT) for the treatment of central retinal artery occlusion (CRAO).

Methods: A systemic review of the literature indexed by Ovid MEDLINE was performed for the following medical subject headings: central retinal artery occlusion, thrombolysis, intra-arterial, fibrinolysis. Studies were analysed individually and categorised by study type, and extracted data grouped together for statistical analysis. Only studies with five patients or more were included in the review.

Results: Twenty-three studies were identified in the original search; eight were selected for the analysis. Of these studies, 158 patients were represented, in which treatment was instituted within an average of 8.4 (SD 4) h of symptom onset. In these patients, visual improvement occurred on average in 93% of patients, with 13% achieving 20/20 or better, 25% achieving 20/40 or better, and 41% achieving 20/200 or better. Complications occurred in 4.5% of cases.

Conclusion: IAT may produce superior visual outcomes compared with conventional treatments for CRAO when instituted in certain situations. At the moment, there is insufficient evidence to support the routine use of IAT to treat CRAO. Well-designed prospective, randomised trials remain to be done.

Statistics from Altmetric.com

Footnotes

  • See Editorial, p 585

  • JN and NW contributed equally.

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles